Article

Get the facts on health care reform

Author(s):

In the summer issue of CURE, we offer some of the specific ways that the new health care reform law will affect cancer patients and their families. While those for and against the new Patient Protection and Affordable health Care Act may disagree whether it will be a positive or negative for the country, everyone agrees that the massive law will require application and interpretation to work out the details. One of the first things we, as a public, need to do is to understand how the law works and how it applies to us. One of the best ways to do this is to read reports from the Kaiser Family Foundation, a nonprofit, private foundation that focuses on the health care issues in the United States. First, the Kaiser Family Foundation has no association with Kaiser Permanente or Kaiser Industries. The foundation develops and runs its own research and communications programs--sometimes in partnership with other nonprofit or research organizations. They research, assess, and report on what is happening in health care at every level, from national policy to basic information. Before you make a determination on the new health care law, get the facts.

Related Videos
Dr. Michael Bogenschutz
Photo credit: Max Mumby/Indigo via Getty Images
Dr. Maxwell Lloyd, a Clinical Fellow in Medicine, in the Department of Medicine, at Beth Israel Deaconess Medical Center in Boston.
1 expert is featured in this series.
Dr. Stephanie Alice Baker
Dr. Aditya Bardia is a professor in the Department of Medicine, Division of Hematology/Oncology, director of Translational Research Integration, and a member Signal Transduction and Therapeutics, at University of California, Los Angeles (UCLA) Health Jonsson Comprehensive Cancer Center.
Dr. Laura Dawson, a professor and chair of the department of Radiation Oncology at the University of Toronto, and a practicing radiation oncologist in the Radiation Medicine Program at Princess Margaret Cancer Center, University Health Network in Toronto.
Dr. Sattva S. Neelapu, a professor and deputy department chair in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, in Houston, as well as a member of Graduate Faculty, Immunology Program, Graduate School of Biomedical Sciences, at The University of Texas Health Science Center, also located in Houston.
Dr. Michael Bogenschutz, director of the NYU Langone Center for Psychedelic Medicine in New York,
Related Content